SINGAPORE, 15 July 2021 – Accredify, a Singapore-based firm that creates and issues verifiable documents, today announced that it has signed an agreement with the International Air Transport Association (IATA) to issue COVID-19 Test Credentials that will be accepted for IATA Travel Pass. This collaboration will make Accredify one of the first lab and clinic aggregators in the Asia Pacific region to participate in the IATA Travel Pass.
With the agreement, COVID-19 test credentials issued by Accredify’s network of healthcare providers in the Asia Pacific region will be securely transmitted to IATA’s Travel Pass. Through Accredify’s numerous international partnerships, travellers will have access to the firm’s constantly growing network of healthcare providers which currently comprises 900 labs and clinics in six markets.
The IATA Travel Pass was developed to provide a secure and privacy-protecting solution for airlines and governments to accurately verify a passenger’s COVID-19 health status. As of July 2021, over 70 airlines are trialing or committed to trial the IATA Travel Pass.
Travellers can visit any Accredify partner clinic to receive their COVID-19 swab test. Once an individual’s swab sample has been analysed, Accredify will simultaneously issue the swab result to the traveller and automatically upload the test result into the IATA Travel Pass. Through the app, travellers can store, access, and display their COVID test results to immigration and airlines who will then verify their status.
“Verified testing is the immediate solution to give governments the confidence to re-open their borders to travelers. IATA Travel Pass aims to make it as simple as possible for travelers to locate certified labs and securely receive the test results that governments require. Adding Accredify’s extensive lab network will help travelers more easily ensure that they meet their COVID-19 travel requirements,” said Nick Careen, IATA’s Senior Vice President, Operations, Safety and Security.
“We are delighted to be working with IATA for this initiative,” said Quah Zheng Wei, Co-founder and CEO, Accredify, “Accredify’s focus has always been on building an internationally interoperable and reliable COVID-19 health verification system which will make it easier for governments to manage an individual’s health status. Our vision is aligned with that of IATA’s, and we look forward to reopening international borders together safely through the Travel Pass Initiative.”
Accredify has been on the forefront of driving the adoption of verifiable COVID-19 health credentials to facilitate domestic and international movement. The firm issued Singapore’s first verifiable COVID-19 test result in October 2020, and co-developed Singapore’s HealthCerts schema, a template for digital COVID-19 test results which has since been mandated by the Singapore government. Since the start of the COVID-19 pandemic, Accredify’s health credentials have been verified close to 6 million times.
To register your interest for Accredify’s issuance system, please email contact@accredify.io
END
About Accredify
Founded in 2019, Accredify is pioneering the adoption of verifiable data by providing organisations with an end-to-end solution to create and issue verifiable documents. With a presence in more than eight markets serving more than 900 clients globally, documents issued by Accredify have been verified close to 7 million times. With a dedicated team that embraces the highest standards of customer service, security, and privacy, Accredify’s objective is to be the trusted solution for managing and verifying documents anywhere and anytime.
For more information, visit www.accredify.io and follow us on LinkedIn @Accredify
Media Contact
Jessica Tan Shu En
Marketing and Communications Lead, Accredify
jessica@accredify.io
